Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment

Blood (2021) 138 (Supplement 1): 822.

https://doi.org/10.1182/blood-2021-152365

Published: 2021

Journal Articles

Immune Checkpoint Blockade Enhances Mutated Calreticulin-Induced T Cell Immunity in Myeloproliferative Neoplasms

Cansu Cimen Bozkus, PhD, John P Finnigan, MDPhDStudent, John Mascarenhas, MD, Ronald Hoffman, MD, Nina Bhardwaj, MD PhD, Camelia Iancu-Rubin, PhD

Blood (2017) 130 (Supplement 1): 384.

https://doi.org/10.1182/blood.V130.Suppl_1.384.384

Published: 2017

Journal Articles

Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies

Camelia Iancu-Rubin, PhD, Helen Fong, PhD, Goar Mosoyan, Ami Patel, MS, Rachel Sabado, PhD, Meseck Marcia, MS, Erin Moshier, MS, Umut Ozbek, PhD, Alla Keyzner, MD, Nina Bhardwaj, MD PhD, Ian K. McNiece, PhD, Jay Tong, MD, Ronald Hoffman, MD

Blood (2016) 128 (22): 818.

https://doi.org/10.1182/blood.V128.22.818.818

Published: 2016

Journal Articles

Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma

Deepak Perumal, PhD, Alessandro Lagana', PhD, Alex Rubinsteyn, PhD, John P Finnigan, Jr., BS, Pei-Yu Kuo, MS, Violetta V Leshchenko, PhD, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Jeff Hammerbacher, BA, Eric Schadt, PhD, Nina Bhardwaj, MD PhD, Samir Parekh, MD

Blood (2015) 126 (23): 1851.

https://doi.org/10.1182/blood.V126.23.1851.1851

Published: 2015

Journal Articles

Dendritic cells and lymphoma cells: come together right now

Nina Bhardwaj, Joshua D. Brody

Blood (2015) 125 (1): 5–7.

https://doi.org/10.1182/blood-2014-11-606608

Published: 2015

Journal Articles

Turning a Tumor into a Vaccine Factory: In Situ Vaccination for Low-Grade Lymphoma

Thomas Marron, MD PhD, Nina Bhardwaj, MD PhD, Elizabeth Crowley, Tibor Keler, PhD, Thomas A. Davis, MD, Joshua Brody, MD

Blood (2014) 124 (21): 5473.

https://doi.org/10.1182/blood.V124.21.5473.5473

Published: 2014

Journal Articles

Evidence of dysregulation of dendritic cells in primary HIV infection

Blood (2010) 116 (19): 3839–3852.

https://doi.org/10.1182/blood-2010-03-273763

Published: 2010

Includes: Supplemental data

Journal Articles

Host Immune Responses Against CT Antigens in Multiple Myeloma Patients.

Nikoletta Lendvai, MD, PhD, Sacha Gnjatic, PhD, Erika Ritter, Yao-Tseng Chen, MD, PhD, Christina Coughlin, MD, PhD, Robert H. Vonderheide, MD, DPhil, Ruben Niesvizky, MD, Nina Bhardwaj, MD, PhD, Selina Chen-Kiang, PhD, Lloyd J. Old, MD, Hearn J. Cho, MD, PhD

Blood (2006) 108 (11): 3492.

https://doi.org/10.1182/blood.V108.11.3492.3492

Published: 2006

Journal Articles

Differential Expression of Type I MAGE in New and Relapsed Multiple Myeloma: Evidence for Association with Proliferation and Progression of Disease.

Hearn J. Cho, MD, PhD, Scott Ely, MD, Wayne R. Austin, AB, Ruben Niesvizky, MD, Roger Pearse, MD, PhD, Morton Coleman, MD, Nina Bhardwaj, MD, PhD, Maurizio DiLiberto, PhD, Selina Chen-Kiang, PhD, Lloyd J. Old, MD, Achim A. Jungbluth, MD

Blood (2006) 108 (11): 3397.

https://doi.org/10.1182/blood.V108.11.3397.3397

Published: 2006

Journal Articles

The apoptotic-cell receptor CR3, but not αvβ5, is a regulator of human dendritic-cell immunostimulatory function

Mojca Škoberne, Selin Somersan, Wanda Almodovar, Tuan Truong, Kseniya Petrova, Peter M. Henson, Nina Bhardwaj

Blood (2006) 108 (3): 947–955.

https://doi.org/10.1182/blood-2005-12-4812

Published: 2006

Includes: Supplemental data

Journal Articles

Expansion of HIV-specific CD4 + and CD8 + T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef

Daniel G. Kavanagh, Daniel E. Kaufmann, Sherzana Sunderji, Nicole Frahm, Sylvie Le Gall, David Boczkowski, Eric S. Rosenberg, David R. Stone, Mary N. Johnston, Bradford S. Wagner, Mohammad T. Zaman, Christian Brander, Eli Gilboa, Bruce D. Walker, Nina Bhardwaj

Blood (2006) 107 (5): 1963–1969.

https://doi.org/10.1182/blood-2005-04-1513

Published: 2006

Journal Articles

CT7 (MAGE-C1)-Specific Cellular Immune Responses in the Bone Marrow Microenvironment of Multiple Myeloma Patients.

Hearn J. Cho, MD, PhD, Len Farol, MD, Jonathan T. Truong, BA, Wayne R. Austin, AB, Yao-Tseng Chen, MD, Nina Bhardwaj, MD, PhD, Ruben Niesvizky, MD, Lloyd J. Old, MD, Selina Chen-Kiang, PhD

Blood (2005) 106 (11): 356.

https://doi.org/10.1182/blood.V106.11.356.356

Published: 2005

Journal Articles

The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation

Achim A. Jungbluth, Scott Ely, Maurizio DiLiberto, Ruben Niesvizky, Barbara Williamson, Denise Frosina, Yao-Tseng Chen, Nina Bhardwaj, Selina Chen-Kiang, Lloyd J. Old, Hearn Jay Cho

Blood (2005) 106 (1): 167–174.

https://doi.org/10.1182/blood-2004-12-4931

Published: 2005

Journal Articles

Killed but Metabolically Active Recombinant Listeria monocytogenes as an Antigen Delivery and Activation Platform for Human Dendritic Cell-Based Cancer Immunotherapy.

Dirk G. Brockstedt, Ph.D., Mojca Skoberne, Ph.D., Alice Yewdall, Keith S. Bahjat, Ph.D., Larry Corash, M.D., Thomas W. Dubensky, Ph.D., Nina Bhardwaj, M.D., Ph.D.

Blood (2004) 104 (11): 3447.

https://doi.org/10.1182/blood.V104.11.3447.3447

Published: 2004

Journal Articles

Manipulating dendritic cell biology for the active immunotherapy of cancer

David W. O'Neill, Sylvia Adams, Nina Bhardwaj

Blood (2004) 104 (8): 2235–2246.

https://doi.org/10.1182/blood-2003-12-4392

Published: 2004

Journal Articles

Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells

Jean Francois Fonteneau, Daniel G. Kavanagh, Margareta Lirvall, Catherine Sanders, Timothy L. Cover, Nina Bhardwaj, Marie Larsson

Blood (2003) 102 (13): 4448–4455.

https://doi.org/10.1182/blood-2003-06-1801

Published: 2003

Journal Articles

Activation of influenza virus–specific CD4 + and CD8 + T cells: a new role for plasmacytoid dendritic cells in adaptive immunity

Jean-François Fonteneau, Michel Gilliet, Marie Larsson, Ida Dasilva, Christian Münz, Yong-Jun Liu, Nina Bhardwaj

Blood (2003) 101 (9): 3520–3526.

https://doi.org/10.1182/blood-2002-10-3063

Published: 2003

Journal Articles

Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus

Marion Subklewe, Ann Chahroudi, Alan Schmaljohn, Michael G. Kurilla, Nina Bhardwaj, Ralph M. Steinman

Blood (1999) 94 (4): 1372–1381.

https://doi.org/10.1182/blood.V94.4.1372

Published: 1999

Journal Articles

A Monocyte Conditioned Medium Is More Effective Than Defined Cytokines in Mediating the Terminal Maturation of Human Dendritic Cells

Anita Reddy, Mark Sapp, Mary Feldman, Marion Subklewe, Nina Bhardwaj

Blood (1997) 90 (9): 3640–3646.

https://doi.org/10.1182/blood.V90.9.3640

Published: 1997

NARROW

Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment

Immune Checkpoint Blockade Enhances Mutated Calreticulin-Induced T Cell Immunity in Myeloproliferative Neoplasms

Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies

Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma

Dendritic cells and lymphoma cells: come together right now

Turning a Tumor into a Vaccine Factory: In Situ Vaccination for Low-Grade Lymphoma

Evidence of dysregulation of dendritic cells in primary HIV infection

Host Immune Responses Against CT Antigens in Multiple Myeloma Patients.

Differential Expression of Type I MAGE in New and Relapsed Multiple Myeloma: Evidence for Association with Proliferation and Progression of Disease.

The apoptotic-cell receptor CR3, but not αvβ5, is a regulator of human dendritic-cell immunostimulatory function

Expansion of HIV-specific CD4 + and CD8 + T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef

CT7 (MAGE-C1)-Specific Cellular Immune Responses in the Bone Marrow Microenvironment of Multiple Myeloma Patients.

The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation

Killed but Metabolically Active Recombinant Listeria monocytogenes as an Antigen Delivery and Activation Platform for Human Dendritic Cell-Based Cancer Immunotherapy.

Manipulating dendritic cell biology for the active immunotherapy of cancer

Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells

Activation of influenza virus–specific CD4 + and CD8 + T cells: a new role for plasmacytoid dendritic cells in adaptive immunity

Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus

A Monocyte Conditioned Medium Is More Effective Than Defined Cytokines in Mediating the Terminal Maturation of Human Dendritic Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only